HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H A Jinnah Selected Research

purine

1/2021Induced pluripotent stem cells from subjects with Lesch-Nyhan disease.
1/2020Physiological levels of folic acid reveal purine alterations in Lesch-Nyhan disease.
1/2016Do clinical features of Lesch-Nyhan disease correlate more closely with hypoxanthine or guanine recycling?
4/2015Consequences of impaired purine recycling on the proteome in a cellular model of Lesch-Nyhan disease.
1/2015Brain white matter volume abnormalities in Lesch-Nyhan disease and its variants.
1/2015Clinical severity in Lesch-Nyhan disease: the role of residual enzyme and compensatory pathways.
8/2014Genotypic and phenotypic spectrum in attenuated variants of Lesch-Nyhan disease.
7/2014Loss of dopamine phenotype among midbrain neurons in Lesch-Nyhan disease.
1/2014Transcriptomic approach to Lesch-Nyhan disease.
12/2013Purine metabolism during neuronal differentiation: the relevance of purine synthesis and recycling.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H A Jinnah Research Topics

Disease

32Dystonia (Limb Dystonia)
01/2022 - 05/2000
31Lesch-Nyhan Syndrome (Choreoathetosis Self Mutilation Hyperuricemia Syndrome)
01/2021 - 04/2000
7Hyperuricemia
01/2020 - 10/2000
6Torticollis (Wryneck)
01/2021 - 12/2013
5Neurodegenerative Diseases (Neurodegenerative Disease)
12/2019 - 06/2001
4Dystonia musculorum deformans type 1
01/2022 - 10/2012
4Nephrolithiasis
08/2014 - 03/2009
4Neuroblastoma
07/2014 - 05/2007
3Dystonic Disorders (Writer's Cramp)
01/2021 - 06/2013
3Nervous System Diseases (Neurological Disorders)
02/2019 - 10/2002
3Pain (Aches)
01/2019 - 10/2002
3Parkinsonian Disorders (Parkinsonism)
12/2017 - 07/2010
3Neurodevelopmental Disorders
01/2016 - 05/2007
3Cognitive Dysfunction
01/2016 - 01/2007
3Gouty Arthritis
08/2014 - 03/2009
3Channelopathies
02/2013 - 09/2002
3Chorea (Rheumatic Chorea)
01/2008 - 09/2002
2Tremor (Tremors)
06/2020 - 02/2008
2Neurologic Manifestations (Neurological Manifestations)
01/2020 - 07/2009
2Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease)
12/2019 - 02/2019
2Stroke (Strokes)
02/2019 - 10/2007
2Mitochondrial Diseases (Mitochondrial Disease)
01/2019 - 03/2008
2Blepharospasm
02/2017 - 03/2001
2Parkinson Disease (Parkinson's Disease)
04/2016 - 07/2009
2Atrophy
10/2012 - 06/2001
2Gout
04/2012 - 07/2009
2Inborn Genetic Diseases (Disease, Hereditary)
08/2009 - 11/2001
2Brain Ischemia (Cerebral Ischemia)
12/2008 - 10/2007
2Phenylketonurias (Phenylketonuria)
01/2004 - 12/2001
2Dyskinesias (Dyskinesia)
10/2002 - 09/2002
1Cerebellar Diseases (Cerebellar Syndrome)
12/2021
1Dopa-responsive Dystonia
01/2021
1Spasm (Spasms)
11/2020
1Aphasia (Dysphasia)
02/2019
1Heart Failure
01/2019
1Deglutition Disorders (Dysphagia)
01/2018
1Dysphonia (Spastic Dysphonia)
02/2017
1Task-Specific Focal Dystonia
01/2017
1Tardive Dyskinesia
02/2015
1Myoclonus (Nocturnal Myoclonus)
12/2014
1Myoclonic dystonia
12/2014
1Renal Insufficiency (Renal Failure)
08/2014
1Metabolic Diseases (Metabolic Disease)
01/2014
1Pheochromocytoma
12/2013
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
04/2013

Drug/Important Bio-Agent (IBA)

28Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA
01/2021 - 04/2000
20EnzymesIBA
01/2021 - 04/2000
19purineIBA
01/2021 - 04/2000
12Uric Acid (Urate)IBA
01/2020 - 05/2006
10Dopamine (Intropin)FDA LinkGeneric
01/2022 - 02/2002
5HypoxanthineIBA
01/2016 - 02/2002
5GuanineIBA
01/2016 - 02/2002
4Biological ProductsIBA
01/2021 - 01/2017
4Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2001
4Calcium Channels (Calcium Channel)IBA
01/2019 - 10/2002
4Botulinum Toxins (Botulinum Toxin)IBA
01/2019 - 06/2016
4TransferasesIBA
07/2009 - 02/2002
3Pharmaceutical PreparationsIBA
01/2019 - 07/2005
3CalciumIBA
01/2019 - 09/2002
3Ion Channels (Ion Channel)IBA
02/2013 - 10/2002
3L-Type Calcium Channels (Dihydropyridine Receptor)IBA
01/2006 - 05/2000
2Cholinergic Agents (Cholinergics)IBA
01/2022 - 01/2019
2Trihexyphenidyl (Artane)FDA LinkGeneric
01/2022 - 01/2019
2Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2022 - 01/2019
2IronIBA
12/2019 - 12/2015
2Dopamine Agonists (Dopamine Agonist)IBA
01/2018 - 12/2017
2ecopipamIBA
04/2016 - 01/2016
2Dopamine D1 Receptors (Dopamine D1 Receptor)IBA
04/2016 - 01/2016
2Nerve Growth Factor (NGF)IBA
04/2015 - 12/2013
2Codon (Codons)IBA
06/2013 - 10/2012
2Ethanol (Ethyl Alcohol)IBA
02/2013 - 10/2002
2Caffeine (No Doz)FDA LinkGeneric
02/2013 - 10/2002
2Kainic Acid (Kainate)IBA
09/2008 - 09/2002
2AntioxidantsIBA
10/2007 - 01/2007
2Methyl ester 1,4- dihydro- 2,6- dimethyl- 5- nitro- 4- (2- (trifluoromethyl)phenyl)- 3-Pyridinecarboxylic acidIBA
11/2003 - 05/2000
2FPL 64176IBA
11/2003 - 05/2000
1Muscarinic M4 ReceptorIBA
01/2022
12- methyl- 4- carboxy- 5- hydroxy- 3,4,5,6- tetrahydropyrimidineIBA
01/2022
1Carisoprodol (Soma)FDA LinkGeneric
12/2021
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2021
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2020
1AICA ribonucleotide (ZMP)IBA
01/2020
1Heavy MetalsIBA
01/2019
1Dihydroxyphenylalanine (Dopa)IBA
01/2019
1Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2019
1AMP Deaminase (Myoadenylate Deaminase)IBA
01/2019
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2019
1Opiate AlkaloidsIBA
04/2018
1Dopamine Receptors (Dopamine Receptor)IBA
01/2018
1abobotulinumtoxinAFDA Link
01/2018
1Dopamine Agents (Dopaminergic Agents)IBA
01/2018
1Levodopa (L Dopa)FDA LinkGeneric
12/2017
1ProteomeIBA
04/2015
1Tetrabenazine (Nitoman)FDA Link
12/2014

Therapy/Procedure

12Therapeutics
01/2022 - 07/2005
5Deep Brain Stimulation
06/2020 - 11/2014
3Activities of Daily Living (ADL)
02/2019 - 12/2014
1Electrodes (Electrode)
11/2020
1Operative Surgical Procedures
01/2019
1Injections
02/2017